Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice
dc.contributor.author | Lew, Denise | en_US |
dc.contributor.author | Parker, Suezanne E. | en_US |
dc.contributor.author | Latimer, Terrie | en_US |
dc.contributor.author | Abai, Anna M. | en_US |
dc.contributor.author | Kuwahara-Rundell, Ann | en_US |
dc.contributor.author | Doh, Soeun Grace | en_US |
dc.contributor.author | Yang, Zhi-Yong | en_US |
dc.contributor.author | Laface, Drake | en_US |
dc.contributor.author | Gromkowski, Stanislaw H. | en_US |
dc.contributor.author | Nabel, Gary J. | en_US |
dc.contributor.author | Manthorpe, Marston | en_US |
dc.contributor.author | Norman, Jon | en_US |
dc.date.accessioned | 2009-07-10T18:59:33Z | |
dc.date.available | 2009-07-10T18:59:33Z | |
dc.date.issued | 1995-05-01 | en_US |
dc.identifier.citation | Lew, Denise; Parker, Suezanne E.; Latimer, Terrie; Abai, Anna M.; Kuwahara-Rundell, Ann; Doh, Soeun Grace; Yang, Zhi-Yong; Laface, Drake; Gromkowski, Stanislaw H.; Nabel, Gary J.; Manthorpe, Marston; Norman, Jon (1995). "Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice." Human Gene Therapy 6(5): 553-564 <http://hdl.handle.net/2027.42/63149> | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/63149 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7578393&dopt=citation | en_US |
dc.description.abstract | Overview summary The present study evaluates the pharmacokinetic half-life and tissue distribution of plasmid DNA following intravenous injection in mice. This study extends the time frame of previous in vivo analyses to 6 months following i.v. injection. Injected mice exhibit no expression of the encoded gene as assayed by immunofluorescence. This represents the first systematic in vivo pharmacokinetic study of intravenously injected DNA complexed with cationic lipids, and is relevant to many gene therapy protocols utilizing direct injection of plasmid DNA plus lipids. The results provide a preliminary basis for the safe initiation of cancer immunotherapy clinical trials in which plasmid DNA is directly injected into tumors. | en_US |
dc.format.extent | 3048703 bytes | |
dc.format.extent | 2489 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Mary Ann Liebert, Inc., publishers | en_US |
dc.title | Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice | en_US |
dc.type | Article | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 7578393 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/63149/1/hum.1995.6.5-553.pdf | |
dc.identifier.doi | doi:10.1089/hum.1995.6.5-553 | en_US |
dc.identifier.source | Human Gene Therapy | en_US |
dc.identifier.source | Human Gene Therapy | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.